Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorKUJAWSKA, Małgorzata
hal.structure.identifierUnité de Recherche Oenologie [Villenave d'Ornon] [OENO]
dc.contributor.authorJOURDES, Michael
dc.contributor.authorKURPIK, Monika
dc.contributor.authorSZULC, Michał
dc.contributor.authorSZAEFER, Hanna
dc.contributor.authorCHMIELARZ, Piotr
dc.contributor.authorKREINER, Grzegorz
dc.contributor.authorKRAJKA-KUŹNIAK, Violetta
dc.contributor.authorMIKOŁAJCZAK, Przemyslaw Łukasz
hal.structure.identifierUnité de Recherche Oenologie [Villenave d'Ornon] [OENO]
dc.contributor.authorTEISSEDRE, Pierre Louis
dc.contributor.authorJODYNIS-LIEBERT, Jadwiga
dc.date.accessioned2021-03-31T14:52:38Z
dc.date.available2021-03-31T14:52:38Z
dc.date.issued2019-12-27
dc.identifier.issn1422-0067en_US
dc.identifier.urioai:crossref.org:10.3390/ijms21010202
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/26844
dc.description.abstractEnPomegranate juice is a rich source of ellagitannins (ETs) believed to contribute to a wide range of pomegranate’s health benefits. While a lot of experimental studies have been devoted to Alzheimer disease and hypoxic-ischemic brain injury, our knowledge of pomegranate’s effects against Parkinson’s disease (PD) is very limited. It is suggested that its neuroprotective effects are mediated by ETs-derived metabolites—urolithins. In this study, we examined the capability of pomegranate juice for protection against PD in a rat model of parkinsonism induced by rotenone. To evaluate its efficiency, assessment of postural instability, visualization of neurodegeneration, determination of oxidative damage to lipids and α-synuclein level, as well as markers of antioxidant defense status, inflammation, and apoptosis, were performed in the midbrain. We also check the presence of plausible active pomegranate ETs-derived metabolite, urolithin A, in the plasma and brain. Our results indicated that pomegranate juice treatment provided neuroprotection as evidenced by the postural stability improvement, enhancement of neuronal survival, its protection against oxidative damage and α-synuclein aggregation, the increase in mitochondrial aldehyde dehydrogenase activity, and maintenance of antiapoptotic Bcl-xL protein at the control level. In addition, we have provided evidence for the distribution of urolithin A to the brain.
dc.language.isoENen_US
dc.sourcecrossref
dc.subject.enurolithin A
dc.subject.enellagic acid
dc.subject.enellagitannins
dc.subject.enpomegranate juice
dc.subject.enrotenone
dc.subject.enantioxidant enzymes
dc.subject.enmitochondrial aldehyde dehydrogenase
dc.subject.enneurodegeneration
dc.subject.enapoptosis
dc.title.enNeuroprotective Effects of Pomegranate Juice against Parkinson’s Disease and Presence of Ellagitannins-Derived Metabolite—Urolithin A—In the Brain
dc.title.alternativeInt. J. Mol. Sci.en_US
dc.typeArticle de revueen_US
dc.identifier.doi10.3390/ijms21010202en_US
dc.subject.halSciences du Vivant [q-bio]/Biologie végétaleen_US
dc.identifier.pubmed31892167en_US
bordeaux.journalInternational Journal of Molecular Sciencesen_US
bordeaux.volume21en_US
bordeaux.hal.laboratoriesOenologie - EA 4577en_US
bordeaux.issue1en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionBordeaux INPen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcedissemin
hal.exportfalse
workflow.import.sourcedissemin
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=International%20Journal%20of%20Molecular%20Sciences&rft.date=2019-12-27&rft.volume=21&rft.issue=1&rft.eissn=1422-0067&rft.issn=1422-0067&rft.au=KUJAWSKA,%20Ma%C5%82gorzata&JOURDES,%20Michael&KURPIK,%20Monika&SZULC,%20Micha%C5%82&SZAEFER,%20Hanna&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée